| GC32899-5mg |
|
1629125-65-0 |
|
0 |
C26H35N3O3 |
|
|
|
| GC32899-2mg |
|
1629125-65-0 |
|
0 |
C26H35N3O3 |
|
|
|
| GC32899-10mM(1mLinDMSO) |
|
1629125-65-0 |
|
0 |
C26H35N3O3 |
|
|
|
| GC32898-10mg |
|
1609452-30-3 |
|
0 |
C15H18Br2N4.xHCl |
|
|
|
| GC32898-5mg |
|
1609452-30-3 |
|
0 |
C15H18Br2N4.xHCl |
|
|
|
| GC32897-5mg |
|
168635-85-6 |
Carcinoembryonic Antigen CEA
|
0 |
C43H68N10O15 |
|
|
|
| GC32897-1mg |
|
168635-85-6 |
Carcinoembryonic Antigen CEA
|
0 |
C43H68N10O15 |
|
|
|
| GC32897-500μg |
|
168635-85-6 |
Carcinoembryonic Antigen CEA
|
0 |
C43H68N10O15 |
|
|
|
| GC32896-25mg |
|
1435192-04-3 |
|
0 |
C24H29N3O2 |
|
|
|
| GC32896-10mg |
|
1435192-04-3 |
|
0 |
C24H29N3O2 |
|
|
|
| GC32896-5mg |
|
1435192-04-3 |
|
0 |
C24H29N3O2 |
|
|
|
| GC32896-10mM(1mLinDMSO) |
|
1435192-04-3 |
|
0 |
C24H29N3O2 |
|
|
|
| GC32895-50mg |
|
57103-68-1 |
Maytansinol (Ansamitocin P-0)
|
0 |
C28H37ClN2O8 |
|
|
|
| GC32895-10mg |
|
57103-68-1 |
Maytansinol (Ansamitocin P-0)
|
0 |
C28H37ClN2O8 |
|
|
|
| GC32895-5mg |
|
57103-68-1 |
Maytansinol (Ansamitocin P-0)
|
0 |
C28H37ClN2O8 |
|
|
|
| GC32895-10mM(1mLinDMSO) |
|
57103-68-1 |
Maytansinol (Ansamitocin P-0)
|
0 |
C28H37ClN2O8 |
|
|
|
| GC32894-50mg |
|
1345407-05-7 |
LTX-315 (K-K-W-W-K-K-W-Dip-K-NH2)
|
0 |
C78H106N18O9 |
|
|
|
| GC32894-25mg |
|
1345407-05-7 |
LTX-315 (K-K-W-W-K-K-W-Dip-K-NH2)
|
0 |
C78H106N18O9 |
|
|
|
| GC32894-10mg |
|
1345407-05-7 |
LTX-315 (K-K-W-W-K-K-W-Dip-K-NH2)
|
0 |
C78H106N18O9 |
|
|
|
| GC32894-5mg |
|
1345407-05-7 |
LTX-315 (K-K-W-W-K-K-W-Dip-K-NH2)
|
0 |
C78H106N18O9 |
|
|
|
